Nur Ink Innovations Past Earnings Performance
Past criteria checks 0/6
Nur Ink Innovations's earnings have been declining at an average annual rate of -33.8%, while the Chemicals industry saw earnings growing at 25.8% annually.
Key information
-33.8%
Earnings growth rate
63.9%
EPS growth rate
| Chemicals Industry Growth | 25.7% |
| Revenue growth rate | n/a |
| Return on equity | -80.0% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We're Not Very Worried About Nur Ink Innovations' (TLV:NURI) Cash Burn Rate
Mar 13
Here's Why We're Not Too Worried About Nur Ink Innovations' (TLV:NURI) Cash Burn Situation
Nov 28We Think Nur Ink Innovations (TLV:NURI) Can Afford To Drive Business Growth
Jul 21Companies Like Nur Ink Innovations (TLV:NURI) Are In A Position To Invest In Growth
Apr 07Revenue & Expenses BreakdownBeta
How Nur Ink Innovations makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -13 | 4 | 9 |
| 30 Sep 23 | 0 | -12 | 4 | 9 |
| 30 Jun 23 | 0 | -12 | 4 | 8 |
| 31 Mar 23 | 0 | -12 | 4 | 7 |
| 31 Dec 22 | 0 | -12 | 5 | 6 |
| 30 Sep 22 | 0 | -11 | 5 | 6 |
| 30 Jun 22 | 0 | -10 | 5 | 5 |
| 31 Mar 22 | 0 | -9 | 4 | 4 |
| 31 Dec 21 | 0 | -8 | 4 | 3 |
| 30 Jun 21 | 0 | -6 | 3 | 2 |
| 31 Mar 21 | 0 | -5 | 2 | 2 |
| 31 Dec 20 | 0 | -4 | 1 | 2 |
Quality Earnings: NURI is currently unprofitable.
Growing Profit Margin: NURI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NURI is unprofitable, and losses have increased over the past 5 years at a rate of 33.8% per year.
Accelerating Growth: Unable to compare NURI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NURI is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-41.5%).
Return on Equity
High ROE: NURI has a negative Return on Equity (-80%), as it is currently unprofitable.